PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsHFEA urges IVF clinics to be more transparent about add-ons

BioNews

HFEA urges IVF clinics to be more transparent about add-ons

Published 13 September 2019 posted in News and appears in BioNews 1015

Author

Rikita Patel

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

The UK fertility regulator, the HFEA, has called for reforms in the way fertility add-on treatments are offered to patients, according to a consensus statement...

The UK fertility regulator, the HFEA, has called for reforms in the way fertility add-on treatments are offered to patients, according to a consensus statement.

IVF clinics in the UK have come under further scrutiny by the HFEA after concerns that a high number of add-on IVF treatments continue to be offered to patients despite no conclusive evidence that they increase the chance of a pregnancy or live birth. Add-on treatments, such as endometrial scratching and assisted egg hatching, are not backed by strong clinical evidence, yet patient demand for these services remains high and so do the costs of treatment. 

Sally Cheshire, chair of HFEA, commented: 'We welcome the introduction of new treatments that could increase the chances of success; however, we want to see responsible innovation. Fertility treatment add-ons are being offered to more patients by clinics and we know many patients are asking for these add-ons and paying for them if they have private treatment.'

The HFEA and ten leading professional and patient fertility groups have published a consensus statement that aims to guide professionals and create a 'cultural change'. The recommendations to clinics include: only offering add-on treatments where more than one high-quality study demonstrates its safety and effectiveness, stopping treatment if concerns are raised regarding safety or effectiveness, informing patients of the experimental nature of add-ons where robust evidence is lacking and not charging patients extra to take part in a clinical trial.

Jason Kasraie, chair of the Association of Clinical Embryologists, said: 'We support greater transparency in the sector with regard to treatment add-ons. Whilst it is important that we work to ensure patients always receive the latest treatments and have access to new technologies in order to maximise their chance of treatment success, it is also essential that we ensure patients are fully informed and that only procedures or technologies that are evidence based are used.'

Earlier this year, the HFEA published a traffic light rating system to help patients identify if a particular add-on treatment is effective and safe for use (see BioNews 983). Despite the warnings from the first report demonstrating the lack of clinical evidence of add-on treatments, it is hoped that the latest consensus statement will ensure that clinics are transparent about add-ons and patients are well informed of their treatment choices.

Cheshire added: 'It's crucial that patients inform themselves about the add-ons they may be offered, so that they can ask the right questions, and make the right choices, when choosing what treatment to have. We've produced "traffic light" rated information on our website that keeps them up-to-date with the latest evidence on each of the most commonly offered add-ons.'

Sources and References

  • 10/09/2019
    The Guardian
    IVF clinics face new crackdown on add-on treatments
  • 12/09/2019
    HFEA
    Fertility regulator calls for clinics to be more open about treatment add-ons

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
10 December 2021 • 6 minutes read

Fertility Across Jurisdictions: International Perspectives

by Dr Antony Starza-Allen

The European regulation of assisted reproductive technologies has troubled policymakers since people started travelling abroad for fertility treatment. The second session of the Progress Educational Trust's annual conference addressed this regulatory challenge with a discussion of highly topical and contentious subjects…

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
26 July 2021 • 4 minutes read

IVF add-ons: are they supported by evidence?

by Sarah Lensen

IVF add-ons are procedures, techniques or medicines which can be used in addition to standard IVF protocols. They are usually offered by IVF clinics, and used by patients, with the hope that they will improve the chance of IVF success...

PET BioNews
Comment
22 January 2021 • 2 minutes read

FILM: An All-Consuming Problem? How to Protect Patients in the Fertility Market

by BioNews

This film documents a Progress Educational Trust event about consumer protection for fertility patients...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
6 November 2020 • 2 minutes read

Draft guidance from watchdog cracks down on IVF clinics

by Martha Roberts

The UK Competition and Markets Authority has released draft guidance for the UK fertility sector, to ensure IVF clinics understand and comply with consumer law...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
8 July 2020 • 2 minutes read

Endometrial scratch has no effect on live birth rate for first time IVF patients

by Catherine Hill

Endometrial scratch, an IVF add-on treatment, has no effect on live birth rate for women undergoing a first IVF or ICSI cycle, study shows...

PET BioNews
Comment
8 July 2019 • 5 minutes read

Is the UK fertility sector facing a tipping point?

by Sally Cheshire

Rarely a day goes by without the UK media mentioning assisted reproduction and the fertility sector. Whether it's the latest research innovation, the growth in DNA testing and matching websites, the funding and commissioning of fertility services or repor

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
5 July 2019 • 2 minutes read

Get A Drip withdraws unproven 'fertility IV'

by Rikita Patel

Wellness company Get A Drip has taken its 'fertility IV' drip off the market after the British Pregnancy Advisory Service (BPAS) said there was no evidence its treatment could improve fertility...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
4 February 2019 • 4 minutes read

The HFEA statement on add-ons in IVF can turn hope into reality

by Dr Kamal Ahuja and 1 others

Recently, the HFEA released a statement on adjunct treatments in IVF. The regulator had provided clear notice of its publication and both its stated intentions and content were as anticipated...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
18 January 2019 • 2 minutes read

HFEA: patients should not pay for unproven IVF 'add-ons'

by Rikita Patel

The Human Fertilisation and Embryology Authority has published a final consensus statement advising that IVF clinics should not charge patients for add-on treatments that are not proven effective by clinical trials...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
14 December 2018 • 1 minute read

Two-thirds of fertility patients feel ripped off by IVF clinics

by Ewa Zotow

Sixty-two percent of private IVF patients paid 'more than they expected' for treatment, according to the first national patient survey by the HFEA.

Leave a Reply Cancel reply

You must be logged in to post a comment.

« DNA company accused of fudging people's genetic test results

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856